Cargando…

Sedation improves early outcome in severely septic Sprague Dawley rats

INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Hong, Sanders, Robert D, Ma, Daqing, Wu, Xinmin, Maze, Mervyn
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750194/
https://www.ncbi.nlm.nih.gov/pubmed/19691839
http://dx.doi.org/10.1186/cc8012
_version_ 1782172224611942400
author Qiao, Hong
Sanders, Robert D
Ma, Daqing
Wu, Xinmin
Maze, Mervyn
author_facet Qiao, Hong
Sanders, Robert D
Ma, Daqing
Wu, Xinmin
Maze, Mervyn
author_sort Qiao, Hong
collection PubMed
description INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to patients randomized to a benzodiazepine-based sedative regimen. We sought to compare the effects of dexmedetomidine and midazolam, at equi-sedative doses, on inflammation and apoptosis in an animal model of severe sepsis. METHODS: After central venous access, Sprague Dawley rats underwent cecal ligation and intestinal puncture (CLIP) with an 18 G needle without antibiotic cover and received either saline, or an infusion of comparable volume of saline containing midazolam (0.6 mg.kg-1.h-1) or dexmedetomidine (5 ug.kg-1.h-1) for 8 hours. Following baseline measurements and CLIP, blood was sampled for cytokine measurement (tumour necrosis factor (TNF)-alpha and interleukin (IL)-6; n = 4-6 per group) at 2, 4 and 5 hours, and animal mortality rate (MR) was monitored (n = 10 per group) every 2 hours until 2 hours had elapsed. In addition, spleens were harvested and apoptosis was assessed by immunoblotting (n = 4 per group). RESULTS: The 24 hour MR in CLIP animals (90%) was significantly reduced by sedative doses of either dexmedetomidine (MR = 20%) or midazolam (MR = 30%). While both sedatives reduced systemic levels of the inflammatory cytokine TNF-alpha (P < 0.05); only dexmedetomidine reduced the IL-6 response to CLIP, though this narrowly missed achieving significance (P = 0.05). Dexmedetomidine reduced splenic caspase-3 expression (P < 0.05), a marker of apoptosis, when compared to either midazolam or saline. CONCLUSIONS: Sedation with midazolam and dexmedetomidine both improve outcome in polymicrobial severely septic rats. Possible benefits conveyed by one sedative regimen over another may become evident over a more prolonged time-course as both IL-6 and apoptosis were reduced by dexmedetomidine but not midazolam. Further studies are required to evaluate this hypothesis.
format Text
id pubmed-2750194
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-27501942009-09-25 Sedation improves early outcome in severely septic Sprague Dawley rats Qiao, Hong Sanders, Robert D Ma, Daqing Wu, Xinmin Maze, Mervyn Crit Care Research INTRODUCTION: Sepsis, a systemic inflammatory response to infective etiologies, has a high mortality rate that is linked both to excess cytokine activity and apoptosis of critical immune cells. Dexmedetomidine has recently been shown to improve outcome in a septic cohort of patients when compared to patients randomized to a benzodiazepine-based sedative regimen. We sought to compare the effects of dexmedetomidine and midazolam, at equi-sedative doses, on inflammation and apoptosis in an animal model of severe sepsis. METHODS: After central venous access, Sprague Dawley rats underwent cecal ligation and intestinal puncture (CLIP) with an 18 G needle without antibiotic cover and received either saline, or an infusion of comparable volume of saline containing midazolam (0.6 mg.kg-1.h-1) or dexmedetomidine (5 ug.kg-1.h-1) for 8 hours. Following baseline measurements and CLIP, blood was sampled for cytokine measurement (tumour necrosis factor (TNF)-alpha and interleukin (IL)-6; n = 4-6 per group) at 2, 4 and 5 hours, and animal mortality rate (MR) was monitored (n = 10 per group) every 2 hours until 2 hours had elapsed. In addition, spleens were harvested and apoptosis was assessed by immunoblotting (n = 4 per group). RESULTS: The 24 hour MR in CLIP animals (90%) was significantly reduced by sedative doses of either dexmedetomidine (MR = 20%) or midazolam (MR = 30%). While both sedatives reduced systemic levels of the inflammatory cytokine TNF-alpha (P < 0.05); only dexmedetomidine reduced the IL-6 response to CLIP, though this narrowly missed achieving significance (P = 0.05). Dexmedetomidine reduced splenic caspase-3 expression (P < 0.05), a marker of apoptosis, when compared to either midazolam or saline. CONCLUSIONS: Sedation with midazolam and dexmedetomidine both improve outcome in polymicrobial severely septic rats. Possible benefits conveyed by one sedative regimen over another may become evident over a more prolonged time-course as both IL-6 and apoptosis were reduced by dexmedetomidine but not midazolam. Further studies are required to evaluate this hypothesis. BioMed Central 2009 2009-08-19 /pmc/articles/PMC2750194/ /pubmed/19691839 http://dx.doi.org/10.1186/cc8012 Text en Copyright ©2009 Qiao et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Qiao, Hong
Sanders, Robert D
Ma, Daqing
Wu, Xinmin
Maze, Mervyn
Sedation improves early outcome in severely septic Sprague Dawley rats
title Sedation improves early outcome in severely septic Sprague Dawley rats
title_full Sedation improves early outcome in severely septic Sprague Dawley rats
title_fullStr Sedation improves early outcome in severely septic Sprague Dawley rats
title_full_unstemmed Sedation improves early outcome in severely septic Sprague Dawley rats
title_short Sedation improves early outcome in severely septic Sprague Dawley rats
title_sort sedation improves early outcome in severely septic sprague dawley rats
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2750194/
https://www.ncbi.nlm.nih.gov/pubmed/19691839
http://dx.doi.org/10.1186/cc8012
work_keys_str_mv AT qiaohong sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats
AT sandersrobertd sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats
AT madaqing sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats
AT wuxinmin sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats
AT mazemervyn sedationimprovesearlyoutcomeinseverelysepticspraguedawleyrats